Dual Anti-OX40/IL-2 Therapy Augments Tumor Immunotherapy via IL-2R-Mediated Regulation of OX40 Expression

por Redmond, William L., Triplett, Todd, Floyd, Kevin, Weinberg, Andrew D.
Publicado 2012

Immune Checkpoint Blockade in Gastrointestinal Cancers: The Current Status and Emerging Paradigms

por Miljanic, Mihailo, Capasso, Anna, Triplett, Todd A., Eckhardt, S. Gail, Aung, Kyaw L.
Publicado 2020

STAT3 signaling is required for anti-OX40/TGF-β receptor blockade-mediated regression of large established tumors

por Akporiaye, Emmanuel T, Tucker, Christopher, Triplett, Todd, Garrison, Kendra, Sun, Lihong, Ling, Leona, Weinberg, Andrew
Publicado 2013

Current methods in translational cancer research

por Lee, Michael W., Miljanic, Mihailo, Triplett, Todd, Ramirez, Craig, Aung, Kyaw L., Eckhardt, S. Gail, Capasso, Anna
Publicado 2020

Anti-HER2 induced myeloid cell alterations correspond with increasing vascular maturation in a murine model of HER2+ breast cancer

por Bloom, Meghan J., Jarrett, Angela M., Triplett, Todd A., Syed, Anum K., Davis, Tessa, Yankeelov, Thomas E., Sorace, Anna G.
Publicado 2020

Longitudinal COVID-19 immune trajectories in patients with neurological autoimmunity on anti-CD20 therapy

por Bazzi, Sam A., Maguire, Cole, Holay, Nisha, Geltman, Janelle, Hurley, Kerin, DiPasquale, Chris, Abigania, Melissa, Olson, Eric, Ehrlich, Lauren I.R., Triplett, Todd A., Melamed, Esther
Publicado 2022

Elucidating the direct effects of the novel HDAC inhibitor bocodepsin (OKI-179) on T cells to rationally design regimens for combining with immunotherapy

por Holay, Nisha, Somma, Alexander, Duchow, Mark, Soleimani, Milad, Capasso, Anna, Kottapalli, Srividya, Rios, Joshua, Giri, Uma, Diamond, Jennifer, Schreiber, Anna, Piscopio, Anthony D., Van Den Berg, Carla, Eckhardt, S. Gail, Triplett, Todd A.
Publicado 2023

Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies

por Anderson, Kristin G, Braun, David A, Buqué, Aitziber, Gitto, Sarah B, Guerriero, Jennifer L, Horton, Brendan, Keenan, Bridget P, Kim, Teresa S, Overacre-Delgoffe, Abigail, Ruella, Marco, Triplett, Todd A, Veeranki, Omkara, Verma, Vivek, Zhang, Fan
Publicado 2023

Reversal of IDO-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme

por Triplett, Todd A., Garrison, Kendra C., Marshall, Nicholas, Donkor, Moses, Blazeck, John, Lamb, Candice, Qerqez, Ahlam, Dekker, Joseph D., Tano, Yuri, Wei-Cheng-Lu, Karamitros, Christos S., Ford, Kyle, Tan, Bing, Zhang, Michelle, McGovern, Karen, Coma, Silvia, Kumada, Yoichi, Yamany, Mena Sameh, Sentandreu, Enrique, Fromm, George, Tiziani, Stefano, Schreiber, Taylor H., Manfredi, Mark, Ehrlich, Lauren I. R., Stone, Everett, Georgiou, George
Publicado 2018